Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Timah Tbk. (TINS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Timah Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Timah Tbk. diperdagangkan di Rp4.740 (kapitalisasi pasar 34,63 T, volume 24 jam 55,06 jt). Perbedaan utamanya: Timah Tbk. jauh lebih besar — sekitar 331,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TINS | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 34,63 T |
Volume | — | 55,06 jt |
Lot | — | 550,59 rb |
Perputaran | — | 257,35 M |
Harga Rata-rata | — | 4.673,99 |
Nilai Transaksi | — | 257,35 M |
Harga Ekuilibrium Indikatif | — | 4.740 |
Volume Ekuilibrium Indikatif | — | 20,88 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Timah Tbk.
PT Timah Tbk (Company) was officially establish by Imas Fatimah, SH by Notarial Deed No.1 dated 2 August 1976. The Company represents a merger of three Dutch Mining companies with operations in Indonesia. The Company’s registration statement in offer 50.330.000 new B class shares at par value of Rp. 500 per share in Indonesia was effective on 27 September 1995. In relation to the offering the new shares, the Government of the Republic of Indonesia also offered 125,825,000 B class shares which were represented by 12,582,500 GDR (each GDR representing 10 B class shares) to the public outside Indonesia. Gross profit for 1999 stand at Rp 751 billion, a figure 45% lower than that achieved in 1998, when gross profits reached Rp 1,362 billion.
Selengkapnya di halaman TINS →
